CYADCelyad

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$15.91M
Vol3,009.00

About

Celyad Oncology SA is a clinical-stage biotechnology company, which focuses on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer. It operates through the following segments: Cardiology and Immuno-Oncology. The Cardiology segment includes the company's Cardiopoiesis, Corquest, and C-Cathez platforms. The Immuno-Oncology segment consists of all assets developed based on the CAR-T cell platform. The company was founded by Michel Lussier, William Wijns, and Christian Homsy on July 24, 2007 and is headquartered in Mont-Saint-Guibert, Belgium.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17

Frequently Asked Questions

What is Market Cap of Celyad Oncology SA - ADR?
What is the 52-week high for Celyad Oncology SA - ADR?
What is the 52-week low for Celyad Oncology SA - ADR?
What is Celyad Oncology SA - ADR stock price today?
What was Celyad Oncology SA - ADR stock price yesterday?
What is the PE ratio of Celyad Oncology SA - ADR?
What is the Price-to-Book ratio of Celyad Oncology SA - ADR?
What is Celyad Oncology SA - ADR's EBITDA?
What is the 50-day moving average of Celyad Oncology SA - ADR?
How many employees does Celyad Oncology SA - ADR have?

Latest CYAD News

View

Advertisement|Remove ads.